The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. [electronic resource]
Producer: 20070718Description: 15271-83 p. digitalISSN:- 0021-9258
- Anthracenes -- pharmacology
- Antibiotics, Antineoplastic -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- drug therapy
- Caspases -- metabolism
- Cell Line, Tumor
- Doxorubicin -- pharmacology
- Drug Resistance, Multiple -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Drug Screening Assays, Antitumor
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Female
- Gene Expression Regulation, Enzymologic -- drug effects
- Gene Expression Regulation, Leukemic -- drug effects
- Humans
- JNK Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Lamin Type A -- metabolism
- MAP Kinase Kinase 4 -- antagonists & inhibitors
- Neoplasm Proteins -- metabolism
- Poly (ADP-Ribose) Polymerase-1
- Poly(ADP-ribose) Polymerases -- metabolism
- Protein Kinase C-delta -- metabolism
- Protein Processing, Post-Translational -- drug effects
- Pyrimidine Nucleosides -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.